Condition
Guttate Psoriasis
Dermatology
Overview
A skin condition, typically emerges suddenly and frequently occurs after an infection such as STREPTOCOCCAL INFECTION. While prevalent among children, it can also manifest in young adults. Its defining feature is the eruption of small, red, scaly patches that typically appear on the arms, legs, and torso.
This information is general and should not be treated as medical advice. Always speak directly with a qualified healthcare professional before making decisions about treatment, diagnosis, procedures, medicines or care.
Quick facts about Guttate Psoriasis
- Topic type
- Condition
- Category
- Dermatology
- MeSH classification
- C17.800.859.675.587
Preparing for an appointment about Guttate Psoriasis
If you are speaking with a healthcare professional about Guttate Psoriasis, it can help to prepare a few details in advance.
- Write down your symptoms and when they started.
- Bring details of any medicines, supplements or previous treatments.
- Ask what tests or assessments may be needed.
- Ask what treatment or management options may be suitable.
- Ask when you should seek urgent medical help or follow-up care.
Finding care related to Guttate Psoriasis
EuroCareFinder helps patients explore clinics and healthcare providers across Europe. Some topics link directly to services offered by clinics, while others may be connected through related specialties, treatments or procedures.
Explore clinics across Europe
Browse the wider EuroCareFinder healthcare network using the interactive map.
Clinics related to Guttate Psoriasis
No clinics are currently linked directly to Guttate Psoriasis on EuroCareFinder.
As more clinics add detailed services, related providers may appear here.
Related topics
Explore healthcare providers
Use EuroCareFinder to browse clinics by country, specialty and available services.
Source: Medical Subject Headings (MeSH), produced by the U.S. National Library of Medicine. EuroCareFinder is not endorsed by the National Library of Medicine. MeSH version: 2026.